Abstract
Individuals with severe combined immunodeficiency (SCID), a group of rare, genetic conditions, are at risk for life-threatening illnesses unless diagnosed and treated early. Even after early identification through newborn screening, parents of children with SCID embark on a complex journey marked by a variety of informational and emotional support needs. This paper explored the types of uncertainties experienced by parents of a child with SCID diagnosed through newborn screening. We conducted semi-structured interviews with 26 parents to discuss the types of uncertainty experienced, including scientific, practical, personal, and existential. Each interview was recorded, transcribed, and coded. Using deductive and inductive content analysis, we describe the type of uncertainty experienced across each stage of the SCID journey. We found that uncertainties in the SCID journey were chronic and multifaceted. Some uncertainties were more prominent at certain points of the journey whereas others spanned multiple stages. Parents expressed a variety of negative emotional reactions to uncertainty, from anxiety, worry, and fear, to doubt, guilt, or grief, and even anger, frustration, and depression. The results speak to the need for healthcare providers to prepare parents for the SCID journey by providing resources to help manage and cope with uncertainty.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
Deidentified data from this study are available through a data use agreement from the corresponding author on request.
References
Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625–55.
Cirillo E, Giardino G, Gallo V, D’Assante R, Grasso F, Romano R, et al. Severe combined immunodeficiency—an update. Ann N Y Acad Sci. 2015;1356:90–106.
Buckley RH, Schiff SE, Schiff RI, Markert ML, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N. Engl J Med. 1999;340:508–16.
Cavazzana-Calvo M, Lagresle C, Hacein-Bey-Abina S, Fischer A. Gene therapy for severe combined immunodeficiency. Annu Rev Med. 2005;56:585–602.
Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.
Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. “Is it going to hurt?”: The impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24:325–35.
Grier J, Hirano M, Karaa A, Shepard E, Thompson JL. Diagnostic odyssey of patients with mitochondrial disease: results of a survey. Neurol Genet. 2018;4:e230.
Dillard JA, Carson CL. Uncertainty management following a positive newborn screening for cystic fibrosis. J Health Commun. 2005;10:57–76.
Bell M, Biesecker BB, Bodurtha J, Peay HL. Uncertainty, hope, and coping efficacy among mothers of children with Duchenne/Becker muscular dystrophy. Clin Genet. 2019;95:677–83.
Hinton D, Kirk S. Living with uncertainty and hope: a qualitative study exploring parents’ experiences of living with childhood multiple sclerosis. Chronic Illn. 2017;13:88–99.
Kerr AM, Haas SM. Parental uncertainty in illness: managing uncertainty surrounding an” orphan” illness. J Pediatr Nurs. 2014;29:393–400.
Raspa M, Lynch M, Squiers L, Gwaltney A, Porter K, Peay H, et al. Information and emotional support needs of families whose infant was diagnosed with SCID through newborn screening. Front Immunol. 2020;11:885.
Babrow AS. Uncertainty, value, communication, and problematic integration. J Commun. 2001;51:553–73.
Brashers DE. Communication and uncertainty management. J Commun. 2001;51:477–97.
Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258–63.
Mishel MH. Uncertainty in illness. Image: J Nurs Scholarsh. 1988;20:225–32.
Han PK, Umstead KL, Bernhardt BA, Green RC, Joffe S, Koenig B, et al. A taxonomy of medical uncertainties in clinical genome sequencing. Genet Med. 2017;19:918–25.
Biesecker BB, Klein W, Lewis KL, Fisher TC, Wright MF, Biesecker LG, et al. How do research participants perceive “uncertainty” in genome sequencing? Genet Med. 2014;16:977–80.
Reyes KG, Clark C, Gerhart M, Newson AJ, Ormond KE. “I wish that there was more info”: characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants. Fam Cancer. 2022;21:143–55.
Kutsa O, Andrews SM, Mallonee E, Gwaltney A, Creamer A, Han PK, et al. Parental coping with uncertainties along the severe combined immunodeficiency journey. Orphanet J Rare Dis. 2022;17:390.
Hill CE, Knox S, Thompson BJ, Williams EN, Hess SA, Ladany N. Consensual qualitative research: an update. J Couns Psychol. 2005;52:196.
Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.
Harris KW, Brelsford KM, Kavanaugh-McHugh A, Clayton EW. Uncertainty of prenatally diagnosed congenital heart disease: a qualitative study. JAMA Netw Open. 2020;3:e204082.
Barben J, Southern KW. Cystic fibrosis screen positive, inconclusive diagnosis. Curr Opin Pulm Med. 2016;22:617–22.
Pruniski B, Lisi E, Ali N. Newborn screening for Pompe disease: Impact on families. J Inherit Metab Dis. 2018;41:1189–203.
Bartley N, Napier CE, Butt Z, Schlub TE, Best MC, Biesecker BB, et al. Cancer patient experience of uncertainty while waiting for genome sequencing results. Front Psychol. 2021;12(Apr):647502.
Sparud-Lundin C, Berg S, Fasth A, Karlsson A, Wekell P. From uncertainty to gradually managing and awaiting recovery of a periodic condition-a qualitative study of parents experiences of PFAPA syndrome. BMC Pediatr. 2019;19:1–9.
Webster M. The cycle of uncertainty: parents’ experiences of childhood epilepsy. Sociol Health Illn. 2019;41:205–18.
Biesecker BB, Erby L. Adaptation to living with a genetic condition or risk: a mini‐review. Clin Genet. 2008;74:401–7.
Madeo AC, O’Brien KE, Bernhardt BA, Biesecker BB. Factors associated with perceived uncertainty among parents of children with undiagnosed medical conditions. Am J Med Genet Part A. 2012;158:1877–84.
Truitt M, Biesecker B, Capone G, Bailey T, Erby L. The role of hope in adaptation to uncertainty: the experience of caregivers of children with Down syndrome. Patient Educ Couns. 2012;87:233–8.
Yanes T, Humphreys L, McInerney-Leo A, Biesecker B. Factors associated with parental adaptation to children with an undiagnosed medical condition. J Genet Couns. 2017;26:829–40.
Lipinski SE, Lipinski MJ, Biesecker LG, Biesecker BB. Uncertainty and perceived personal control among parents of children with rare chromosome conditions: the role of genetic counseling. Am J Med Genet Part C Semin Med Genet. 2006;142:232–40.
Zhong L, Woo J, Steinhardt MA, Vangelisti AL. “Our job is that whole gray zone in between there”: investigating genetic counselors’ strategies for managing and communicating uncertainty. Health Commun. 2020;35:1583–92.
Acknowledgements
We would like to extend our heartfelt thanks to the families who participated in this study. We are grateful for their time and input.
Funding
This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2.97 million with 0% financed with nongovernmental sources. The contents are those of the author(s)and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.
Author information
Authors and Affiliations
Contributions
MR, SMA, AYG, AC, and BBB were involved in study design and conceptualization. SMA and AYG collected the data. MR, OK, SMA, AYG, EM, and BBB analyzed and interpreted the data. MR, OK, SMA, AYG, EM, PKJH, and BBB were involved in writing and reviewing the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was reviewed and approved by the RTI International Institutional Review Board. Participants provided informed consent prior to data collection.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Raspa, M., Kutsa, O., Andrews, S.M. et al. Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening. Eur J Hum Genet 32, 392–398 (2024). https://doi.org/10.1038/s41431-023-01345-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-023-01345-5
This article is cited by
-
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultations
Orphanet Journal of Rare Diseases (2025)
-
Artificial intelligence – the next generation of sequencing?
European Journal of Human Genetics (2024)
-
What is health and what do we mean when we say an intervention improves health?
European Journal of Human Genetics (2024)
-
Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia
Journal of Clinical Immunology (2024)


